Shares of Moderna, Inc. ($MRNA), among the frontrunners in mRNA vaccine technology, fell on Tuesday, bucking the broader market strength. The weakness came after Bloomberg reported, citing a person ...

Editorial writers discuss these public health issues.

Heading into Moderna’s third-quarter earnings, investors and analysts will be watching to see how the Cambridge drugmaker ...

Four men have been diagnosed with Trichophyton mentagrophytes type VII since spring. Also, whooping cough cases — almost 20,000 — are almost back to pre-pandemic levels; California and Washington ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Donald Trump’s pledge to let Robert F. Kennedy Jr. “go wild on health” has put three issues on the agenda in the final days ...

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...

Protection from flu vaccines takes a couple of weeks to kick in, so getting one now may protect you ahead of the holidays.

Influenza A is the most common variant of the flu and the one you’re most likely to get during pregnancy. A flu shot is the ...

In the closing days of the presidential campaign, former President Donald Trump and some of his top allies have increasingly ...

The vaccine conspiracy theorist is preparing post-inauguration plans and vetting underlings for a position in Trump's ...

Influenza and 2023 to 2024 COVID-19 vaccination coverage is 80.7 and 15.3%, respectively, among health care personnel at ...